Cells that express a point mutation that changes amino acid position 110 from glycine to arginine in IGLV3-21 trigger autonomous B-cell receptor (BCR) signalling by BCR-BCR interaction and confer aggressive behaviour in CLL [76]. The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.